Nuvalent Inc News, Nuvalent Inc Quote, NUVL Quote

Nuvalent Inc (NQ:NUVL) Delayed: 62.76 -0.3 (0.48%)

Prev. Close

$63.06

Open

$62.95

52 Wk High

$0.40

52 Wk Low

$0.14

Day High

$64.71

Day Low

$61.80

P/E

N/A

EPS

$-0.56

Volume

1,245,959

Apr 17, 2024 04:46 PM Form 4 Nuvalent, Inc. For: Apr 15 Filed by: Shair Matthew
Apr 17, 2024 04:45 PM Form 4 Nuvalent, Inc. For: Apr 15 Filed by: Conley Emily
Apr 17, 2024 12:18 AM Jefferies Starts Nuvalent (NUVL) at Buy, 'Precisely Targeted Oncology Aiming for Firstline Treatment'
Apr 10, 2024 04:45 PM Form 4 Nuvalent, Inc. For: Apr 08 Filed by: Shair Matthew
Apr 8, 2024 04:30 PM Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024
Apr 5, 2024 04:47 PM Form 4 Nuvalent, Inc. For: Apr 04 Filed by: Miller Deborah Ann
Apr 3, 2024 04:45 PM Form 4 Nuvalent, Inc. For: Apr 01 Filed by: Shair Matthew
Apr 1, 2024 06:10 AM Leerink Partners Upgrades Nuvalent (NUVL) to Outperform
Mar 29, 2024 05:17 PM Form SC 13D/A Nuvalent, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
Mar 29, 2024 05:15 PM Form 4 Nuvalent, Inc. For: Mar 27 Filed by: Hack Andrew A. F.

Entities mentioned with NUVL